论文部分内容阅读
上海第一医学院药学系物理化学教研室马远鸣副教授与肿瘤医院同位素室蒋长英医师,自1981年3月开始协作,经过2年多反复试验,研制成功一种新型的淋巴结显象剂~(99m)锝-脂质体,具有安全,显象清晰和无副作用等优点。他们与有关单位先后完成了制剂的研制与质量监测、药理试验及临床试用等项目。据统计共做腹膜后淋巴结显象90人次,腕骨旁淋巴结显象13人次,颈部淋巴结显象7人次,纵隔淋巴结显象9人次;共计119人次,无1例发生不良反应。其中23例经手木、
Dr. Ma Yuanming, Associate Professor of Department of Physical Chemistry, Department of Pharmacy, Shanghai First Medical College, and Dr. Jiang Changying, Department of Isotopes, Cancer Hospital, began collaborating in March 1981. After more than two years of trial and error, a new type of lymph node imaging agent (99m) was successfully developed. - Liposomes, with safety, clear imaging and no side effects. They and related units have completed the preparation of the preparations and quality monitoring, pharmacological tests and clinical trials. According to statistics, a total of 90 retroperitoneal lymph node images were performed, 13 paravertebral lymph nodes were imaged, 7 lymph nodes were visualized, and 9 were mediastinal lymph nodes. A total of 119 patients had no adverse reactions. Of these, 23 cases were handled